C.M. Bidwell & Associates’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-4,425
| Closed | -$204K | – | 439 |
|
|
2018
Q3 | $204K | Buy |
4,425
+1,645
| +59% | +$75.8K | 0.19% | 134 |
|
|
2018
Q2 | $104K | Buy |
+2,780
| New | +$104K | 0.1% | 180 |
|
|
2016
Q2 | – | Sell |
-3,950
| Closed | -$148K | – | 291 |
|
|
2016
Q1 | $148K | Buy |
+3,950
| New | +$148K | 0.04% | 203 |
|
|
2014
Q4 | – | Sell |
-8,425
| Closed | -$325K | – | 234 |
|
|
2014
Q3 | $325K | Hold |
8,425
| – | – | 0.08% | 111 |
|
|
2014
Q2 | $328K | Hold |
8,425
| – | – | 0.07% | 108 |
|
|
2014
Q1 | $288K | Buy |
+8,425
| New | +$288K | 0.07% | 117 |
|
|
2013
Q4 | – | Sell |
-88,520
| Closed | -$2.08M | – | 240 |
|
|
2013
Q3 | $2.08M | Sell |
88,520
-505
| -0.6% | -$11.9K | 0.57% | 86 |
|
|
2013
Q2 | $2.39M | Buy |
+89,025
| New | +$2.39M | 0.7% | 75 |
|